Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Biopharmaceutical company moves ahead with cost rationalization plan
April 21st, 2005
Novavax, Inc., (NVAX) announced additional measures to control expenses by reducing the size of its sales force. This move will more efficiently align the number of sales representatives required to support the existing base of ESTRASORB prescribing physicians while allowing the company to continue to cover the highest prescribing obstetricians and gynecologists to grow sales of its women's health products. Following a detailed analysis of the opportunities in its sales territories balanced with a return on investment analysis, the company concluded that it was in its best interest to restructure to 40 sales positions. The company...
Source: Women's Health Weekly (2005-04-21)
|
